TrademarkDir
BEAM THERAPEUTICS
LIVE

Serial Number

98209503

Owner

Beam Therapeutics Inc.

Attorney

John V. Hobgood, Esquire

First Use Date

Aug 7, 2023

Filing Date

Oct 4, 2023

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

BEAM THERAPEUTICS Trademark

Serial Number: 98209503

BEAM THERAPEUTICS is a trademark filed by Beam Therapeutics Inc. on October 4, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Beam Therapeutics Inc. (10 trademarks)

Cambridge, MA 02142

Entity Type: 03

Trademark Details

Filing Date

October 4, 2023

Registration Date

Not Registered

First Use Anywhere

August 7, 2023

First Use in Commerce

November 17, 2023

Published for Opposition

October 8, 2024

Goods & Services

Pharmaceutical and biological preparations based on base editing, base modification, nucleobase editing, nucleobase modification, nucleic acid editing, gene editing, gene modification, gene modulation, gene therapy, genome editing, genome modification, cell therapy, cellular modification, tissue modification, and organ modification for use in human therapeutics for the treatment of Sickle Cell Disease, Alpha-1 Antitrypsin Deficiency, and Glycogen Storage Disease Ia

Filing History

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Aug 12, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Aug 12, 2026 CNPR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 12, 2026 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Aug 11, 2026 SUPC
SOU EXTENSION 3 GRANTED
Aug 11, 2026 EX3G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 11, 2026 AITU
SOU EXTENSION 3 FILED
May 18, 2026 EXT3
SOU TEAS EXTENSION RECEIVED
May 18, 2026 EEXT
USE AMENDMENT FILED
Apr 21, 2026 IUAF
TEAS STATEMENT OF USE RECEIVED
Apr 21, 2026 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 18, 2025 EXRA
SOU EXTENSION 2 GRANTED
Nov 17, 2025 EX2G
SOU EXTENSION 2 FILED
Nov 17, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 17, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 15, 2025 EXRA
SOU EXTENSION 1 GRANTED
May 14, 2025 EX1G
SOU EXTENSION 1 FILED
May 14, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
May 14, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 19, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 8, 2024 NPUB
PUBLISHED FOR OPPOSITION
Oct 8, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 18, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 4, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 22, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 22, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 22, 2024 TROA
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
May 30, 2024 GEAN
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
May 30, 2024 GEAP
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
May 30, 2024 EPEN
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
May 30, 2024 CPEA
ASSIGNED TO EXAMINER
May 24, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 13, 2023 NWOS
NEW APPLICATION ENTERED
Oct 7, 2023 NWAP

Related Trademarks

More from this Owner

FLIGHT THERAPEUTICS

FLIGHT THERAPEUTICS

BEAMLINK

BEAMLINK

BEAMPATH

BEAMPATH

RELYSTEN

RELYSTEN

ZELRISTY

ZELRISTY

ZELRISTY

ZELRISTY